A Smart + Strong Site
Subscribe to:
POZ magazine

Back to home » Treatment News » Top Stories

March 31, 2008
Genes Predict Immune Response to Antiretroviral Treatment
A set of mutations to a person’s genes predicted how completely their immune system recovered after starting antiretroviral therapy, say the authors of a study to be published in a forthcoming issue of Nature Medicine and reported by Newswise.
March 28, 2008
More HIV Cases Reported in 2006
The Centers for Disease Control and Prevention’s (CDC) newly published 2006 HIV/AIDS Surveillance Report estimates that there were 52,878 new cases of HIV in 2006.
March 27, 2008
Some People Not Appropriately Treated for High Cholesterol
Some HIV-positive people at high risk for heart disease are not having their levels of “bad” LDL cholesterol managed as aggressively as treatment guidelines recommend, say the authors of a single-clinic study published in the April 15 issue of Clinical Infectious Diseases.
March 26, 2008
Lower-Dose Zerit May Improve Some Side Effects
Halving the dose of Zerit (stavudine) may reduce the risk of serious side effects without compromising its efficacy, say researchers of a study published in the April 15 issue of Clinical Infectious Diseases.
March 25, 2008
Charting the Future of Protease Monotherapy
It has been suggested that using a Norvir (ritonavir)-boosted protease inhibitor (PI) without the use of other antiretrovirals to treat HIV is less effective, and more likely to cause drug resistance, than standard three-drug regimens in clinical trials.
March 24, 2008
Group Psychotherapy Improves Mood, but Not Adherence
A 12-week course of specialized psychological group counseling improved mood and quality of life in people living with HIV, but did not improve CD4 count, viral load or adherence to antiretroviral therapy, according to a study published in the March 30 issue of AIDS.
Food Poisoning May Be Fatal for People With HIV
A new study conducted by scientists from the University of California Davis School of Medicine reveals that people living with HIV are more at risk for lethal Salmonella infection than HIV-negative people, ScienceDaily reports.
March 21, 2008
PIs Increase Heart Disease Risk, and NNRTIs Decrease It
Protease inhibitors (PIs) are associated with increased blood levels of fibrinogen—a marker of heart disease risk—whereas non-nucleoside reverse transcriptase inhibitors (NNRTIs) are associated with decreased blood levels of fibrinogen, according to a study published in the March 30 issue of AIDS.
March 20, 2008
Tenofovir Better Tolerated Than Zidovudine for PEP
Nonoccupational post-exposure prophylaxis (NPEP) regimens containing tenofovir were better tolerated and more likely to be completed than those containing zidovudine, according to a study conducted at the Fenway Community Health center in Boston and reported in the April 1 issue of the Journal of Acquired Immune Deficiency Syndromes (JAIDS).
March 19, 2008
Some Genetically Protected Against Lipoatrophy
Some people have genetic mutations that protect them from lipoatrophy, the loss of fat beneath the skin in the face and limbs caused by some HIV drugs, while others have genes that make them more vulnerable, say the authors of a new study published in the Journal of Infectious Diseases and reported by AIDSmap.
March 18, 2008
Mental Illness and Substance Use Delay HIV Treatment
People with untreated mental illness or substance abuse, or both together, start HIV treatment later than people without mental illness or substance abuse, according to a study published in the March 1 issue of AIDS Patient Care and STDs.
March 17, 2008
Universal Health Care Doesn’t Ensure Universal HIV Treatment
Forty percent of all those who died of AIDS in British Columbia, a province in Canada with true universal access to HIV care and treatment, died without having accessed HIV treatment, according to a study published in the April 1 issue of the Journal of Acquired Immune Deficiency Syndromes.
March 14, 2008
Trust for Doctors High in French Study
Though the vast majority of people living with HIV surveyed in France had a high degree of trust in their HIV doctor, a small percentage began to lose trust over time, say the authors of a new study.
March 13, 2008
Prezista Warning: Liver Problems Possible
Tibotec has updated its prescribing information for the protease inhibitor Prezista to include a warning about possible liver toxicity, according to a letter being sent to health care providers by the company in cooperation with the FDA.
Race and Gender Impact HIV Treatment Side Effects
Race and gender play a role in what side effects a person is likely to experience when starting an antiretroviral drug regimen, according to a study published in the April 1 issue of the Journal of Acquired Immune Deficiency Syndromes.
March 12, 2008
Mentally Ill and Substance Users Not Getting Care
A significant percentage of people living with HIV who have a diagnosed mental illness or a substance abuse problem, or both, are not getting appropriate treatment, according to a study published in the April 1 issue of the Journal of Acquired Immune Deficiency Syndromes.
March 11, 2008
Fish Oil and Fenofibrate an Effective Combo for High Triglycerides
The combination of fish oil with fenofibrate was more effective than either treatment alone in reducing triglycerides to desired levels in people living with HIV, according to a study published in the April 1 issue of the Journal of Acquired Immune Deficiency Syndromes.
March 10, 2008
Test for Abacavir Hypersensitivity Works in Black and White Patients
The HLA-B*5701 test to predict who will have a hypersensitivity reaction (HSR) to abacavir (found in Ziagen, Epzicom and Trizivir) works equally well in black and white patients with HIV, according to a study published in the April 1 issue of Clinical Infectious Diseases.
March 07, 2008
Genetically Reprogrammed Cells Could Battle HIV
Genetically reprogramming infection-fighting cells known as CD8 cytotoxic T lymphocytes (CTLs) made them especially efficient at wiping out HIV in laboratory experiments, report researchers at the Albert Einstein College in the Bronx.
March 06, 2008
Neuropathy Pain Patch Fails Test
A dermal patch that releases the experimental drug NGX-4010 for HIV-related distal sensory polyneuropathy (DSP), a painful condition caused by nerve damage, failed to perform better than a placebo in a phase III trial, according to NeurogesX, the developer of the compound.
Bevirimat Success Hinges on HIV Mutations
The experimental maturation inhibitor, Bevirimat (PA-457), is most effective in people whose virus does not carry a specific group of genetic mutations in HIV’s Gag protein, announced the drug’s developer, Panacos.
March 05, 2008
HIV-Positive Women Remain Slimmer but Have Higher Waist-to-Hip Ratios
HIV-positive women have high waist-to-hip ratios (WHR), a potential risk factor for heart disease, despite being less overweight than HIV-negative women, according to a study published in the March 1 issue of the Journal of Acquired Immune Deficiency Syndromes.
March 04, 2008
Pneumonia Vaccine Effective in HIV
People with HIV who are given the pneumococcal polysaccharide vaccine (PPV) are 35 percent less likely to develop pneumonia than those who are not vaccinated, according to a new study to be published in an upcoming issue of Clinical Infectious Diseases.
March 03, 2008
Disalcid Improves Inflammation, But Has Liver Toxicity
The anti-inflammatory drug Disalcid (salsalate) reduces blood vessel inflammation, which may decrease the risk of a heart attack in people living with HIV, according to study results published in the March 12 issue of AIDS.
Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
FDA Approves New Single-Tablet HIV Regimen, Triumeq
Life Expectancy for Young People With HIV Is Nearly Normal
A 15-Year Jump in Life Expectancy for People With HIV
Scientists Devise Method of Snipping HIV From Immune Cells
Monkey HIV Vaccine Success Opens Door for Human Trials
HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir
Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?

February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
February 2006
October 2005

Quick Links
About HIV and AIDS
The Cure
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Conference Coverage
Health Services Directory
POZ Magazine
AIDSmeds on Twitter

Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014

21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014

7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013

more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.